Expression of Genes Encoding Cell Motility Proteins during Progression of Head and Neck Squamous Cell Carcinoma


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The model of head and neck squamous cell carcinoma (HNSCC) was used to study the expression of genes encoding actin-binding proteins depending on the type of cell motility. The expression of SNAIL1 and CAPN2 mRNA in HNSCC tissue was higher than in specimens of dysplastic epithelium of the larynx and hypopharynx, which can be explained by activation of mesenchymal and amoeboid types of cell motility. In biopsy material of HNSCC patients with T1-2N0M0, expression of genes responsible for actin-binding proteins differed from that of patients with pretumor pathology of the larynx and hypopharynx: expression of FSCN was lower, while expressions of EZR and CAP1 were higher. The data attest that progression of HNSCC is associated with activation of both types of cell motility and with the changes in the expression of mRNA encoding cell motility proteins.

About the authors

O. V. Cheremisina

Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences

Email: kakurinagv@oncology.tomsk.ru
Russian Federation, Moscow

V. A. Novikov

Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences

Email: kakurinagv@oncology.tomsk.ru
Russian Federation, Moscow

E. L. Choinzonov

Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences; Siberian State Medical University

Email: kakurinagv@oncology.tomsk.ru
Russian Federation, Moscow; Tomsk

G. V. Kakurina

Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences

Author for correspondence.
Email: kakurinagv@oncology.tomsk.ru
Russian Federation, Moscow

I. V. Kondakova

Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences

Email: kakurinagv@oncology.tomsk.ru
Russian Federation, Moscow

L. V. Spirina

Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences; Siberian State Medical University

Email: kakurinagv@oncology.tomsk.ru
Russian Federation, Moscow; Tomsk

E. S. Kolegova

Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences

Email: kakurinagv@oncology.tomsk.ru
Russian Federation, Moscow

E. E. Shashova

Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences

Email: kakurinagv@oncology.tomsk.ru
Russian Federation, Moscow

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Springer Science+Business Media, LLC, part of Springer Nature